Metabolic effects of antipsychotics in children.
Phase of Trial: Phase IV
Latest Information Update: 22 Jun 2018
At a glance
- Drugs Aripiprazole (Primary) ; Olanzapine (Primary) ; Risperidone (Primary)
- Indications Behavioural disorders; Psychotic disorders
- Focus Pharmacodynamics
- Acronyms MEAC
- 31 Aug 2018 Biomarkers information updated
- 02 Aug 2011 Additional lead trial investigator (Ginger Nicol) identified as reported by ClinicalTrials.gov.
- 02 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History